Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2921 of 5804
-
Sweat and surgery: a One-Two punch against nerve damage?
Knowledge-focused CompletedThe purpose of this research study is to evaluate how exercise and surgical weight loss affect how likely an individual is to develop peripheral neuropathy and other neurologic complications.
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Experimental drug aims to supercharge immune system before cancer surgery
Disease control CompletedThis clinical trial will evaluate the safety and feasibility of a humanized OX40 agonist, MEDI0562, in the pre-operative setting for patients with head and neck squamous cell carcinoma or melanoma.
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a common acid reflux drug keep kids Ulcer-Free?
Disease control CompletedThis is an open label, parallel group, multi-centre, phase III study to assess the safety and efficacy of D961H in maintenance therapy following initial healing therapy in Japanese paediatric patients with reflux esophagitis, and to assess the safety and efficacy of D961H in Japa…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New MRI scan spots hidden fat clues to breast cancer
Diagnosis OngoingThe role of fat in breast cancer development and growth has been studied extensively using body mass index, a measure of whole body fatness, and dietary fat intake in a number of epidemiological studies. However, there is a paucity of studies, on an individual level, to assess th…
Phase: NA • Sponsor: NYU Langone Health • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Can fish oil and vitamin d help preserve insulin in type 1 diabetes?
Disease control CompletedThe investigator propose to test the safety and efficacy of a regimen that combines Omega-3 Fatty Acids and Vitamin D in a design that considers timing and duration of administration in relation to their effects and predicted synergies.
Phase: PHASE1, PHASE2 • Sponsor: Rodolfo Alejandro • Aim: Disease control
Last updated Jun 26, 2026 17:29 UTC
-
New device aims to loosen stiff legs in stroke survivors
Symptom relief CompletedThis is a single center, randomized, double-blind (patient and evaluator), sham-controlled study. The main objectives of this study are to evaluate the performance and safety of the MyoRegulator® device in active versus sham treated stroke patients with lower-limb spasticity afte…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Phone therapy eases cancer Survivors' distress in rural areas
Symptom relief CompletedMental health issues in post-treatment adult cancer survivors are associated with multiple adverse outcomes and may represent a cancer health disparity for rural survivors. The purpose of this study is to test a stepped-care approach tailored to symptom severity based on recent A…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New drug shows promise for Tough-to-Treat seizures in kids
Disease control TerminatedThe main aim is to assess the long-term safety and tolerability of soticlestat when used along with other anti-seizure treatment. Participants will receive soticlestat twice a day. Participants will visit the study clinic every 2-6 months throughout the study. Study treatments …
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Mind-Body PT boosts recovery after severe leg injuries
Symptom relief CompletedThe goal of the CBPT study is to determine the efficacy of the CBPT program for improving outcomes in service members and civilians at-risk for poor outcomes following traumatic lower-extremity injury. Primary outcome is physical function measured through a patient-reported quest…
Phase: NA • Sponsor: Major Extremity Trauma Research Consortium • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a daily antibiotic stop deadly infections in blood cancer patients?
Disease control CompletedInfections are a major life-threatening complication in patients with myelodysplastic syndrome (MDS) or acute myeloid leukaemia (AML). Currently there is no guidelines about antibacterial prophylaxis to prevent infections in patients with myelodysplastic syndrome or acute myeloid…
Phase: PHASE3 • Sponsor: Centre Henri Becquerel • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a video game help Parkinson's patients walk better?
Symptom relief CompletedTo test the effects of a serious game rehabilitation programme in 50 patients with Parkinson's disease with gait and balance disorders in a randomised controlled study
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Can genes and drug levels predict transplant success?
Knowledge-focused Recruiting nowThis study will examine the influence of donor and recipient pharmacogenetics (PG), drug pharmacokinetics (PK), and T cell phenotypes and how it may permit a tailored dosing strategy to improve the therapeutic index of post-transplant cyclophosphamide (PTCy) and optimize the graf…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Phone coaching and app help adults lower heart risk
Prevention CompletedThis study evaluates a digital health prevention program combining digital tools and structured telephonic coaching to support adult participants in improving health-related behaviors and well-being. Participants voluntarily enrolled in an ongoing prevention program offering per…
Phase: NA • Sponsor: Vivoptim Solutions • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
New cancer drug shows promise in early human trial
Disease control CompletedThe purpose of the study is to identify the maximum tolerated dose (MTD) of JNJ-64619178 in participants with relapsed/refractory B cell non-Hodgkin lymphoma (NHL) or advanced solid tumors and also to identify the recommended Phase 2 dose(s) (RP2Ds) of JNJ-64619178 for NHL and ad…
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can new sound coding unlock better hearing for kids with cochlear implants?
Knowledge-focused Recruiting nowThe purpose of this study is to understand performance with a cochlear implant. The long-term goals of this research are to improve sound perception with cochlear implants and to better understand the functioning of the auditory system. Information from individuals with and witho…
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Spray-on drug may cut blood loss in major spine surgery
Disease control Recruiting nowPosterior spinal surgery for adult deformity is associated with high incidence of blood loss and need for blood transfusion and intraoperative blood salvage, with associated increased cost and risk for perioperative complications. Tranexamic acid (TXA) is relatively inexpensive a…
Phase: PHASE3 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New pill HQP1351 enters human testing for stubborn cancers
Disease control Recruiting nowThis study is a Multi-center, Open-label Phase 1 Study to Determine the Recommend Phase 2 Dose (RP2D) and Evaluate PK/PD and preliminary Efficacy of HQP1351 in Patients With GIST or Other Solid Tumors.
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo shows promise in early trial for advanced cancers
Disease control CompletedThis study consists of several parts: dose escalation, dose expansion, dose expansion in Chinese participants residing in China, and coformulation. Dose escalation is to evaluate the safety, tolerability, and preliminary efficacy of MK-4830 monotherapy administration (Arms A and …
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New vitamin d pill aims to tame parathyroid glands in dialysis patients
Disease control TerminatedSafety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI
Phase: PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can heart scans predict trouble in tetralogy of fallot patients?
Knowledge-focused OngoingThis study aims to study the correlation between biomarkers of myocardial fibrosis (extracellular volume fraction calculated by cardiac magnetic resonance imaging (MRI) (T1-mapping) and levels of molecular biomarkers of fibrosis) and adverse events in a population of patients wit…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC